News from Asia

Mon Nov 6

CK Life Sciences Presenting Preclinical Data for Its Investigational Dual-Antigen Cancer Vaccines, Co-targeting PRAME and PD-L1, at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Written by Viw Magazine

HONG KONG SAR - Media OutReach - 1 November 2023 - CK Life Sciences Int'l., (Holdings) Inc. is presenting preclinical data for its investigational dual-antigen cancer vaccines, co-targeting PRAME (preferentially expressed antigen in melanoma) and PD-L1 (programmed death-ligand 1), on November 4 at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting in San Diego, California, USA.

How To Survive and Thrive The Retail Apocalypse
In this difficult retail climate, malls are falling, retail vacancies are rising, and shoppers rarely come to the ground. Does this mean the mall is dead? The convenience offered by the m…
Property Valuation is an Essential Tool for Divorce Settlements
Property valuation for divorce settlements are a critical step in the divorce process. Both parties need to understand the value of all assets so that an appropriate and equitable division…
Best Ideas For Car Park Shade Structures
Every home does not come with a proper garage or space for parking your car. You need to focus on different ideas while you are willing to construct a new shade for your car parking. The…
What causes SIDS? What we know, don’t know and suspect
Discovering causes of SIDS is difficult, since diagnosis is one of exclusion.from www.shutterstock.comSudden infant death syndrome (SIDS) is a devastating and unexpected event in which a see…
Top 5 Food Cities in China
Savvy travellers are getting a jump on the peak travel period by visiting the world's most populous country – China – in spring, to take pleasure in the best of its authentic food as wel…